LATEST NEWS

The Einav lab aims to stop deadly viruses by leveraging the vast wealth of data we acquire on the immune system
LJI scientists find MAIT cells can be tuned to fight different pathogens via their metabolism, paving the way for new therapeutic strategies
San Diego scientists work with business experts to advance dengue and Zika virus vaccine strategy
In this seminar, Florian Krammer, Ph.D. from the Mount Sinai School of Medicine, discussed antibody responses to SARS-CoV-2 and new
In this seminar, Dr. Jon Yewdell, M.D., Ph.D., of NIAID, covers topics related to viral protein translations, the mechanisms of
A letter from LJI President and CEO Erica Ollmann Saphire, Ph.D.
How a very exposed organ fights disease
How LJI’s new Chief Operating Officer defines “mission success”
Remembering Shelley Rowland
New innate immune system research—and a prestigious ARCS Award—could enhance future vaccines
Scientists often compare starting a new lab to starting a small business. It takes finding the right people and solid funding to make the dream work. Assistant Professor Samuel Myers, Ph.D., shares an honest look at what it’s like to start a new lab at La Jolla Institute for Immunology (LJI).
Research on the edge of the immune system